Skip to main content
Not Found
Digital Seminar

Practical Psychopharmacology: Application-to-Practice Strategies for Prescribers, Mental Health Clinicians & Nursing Professionals


Speaker:
David Dadiomov, PharmD, BCPP
Duration:
4 Hours 16 Minutes
Language:
Presented in EN, subtitles in EN and FR, handouts in EN and FR
Format:
Audio and Video
Copyright:
Oct 10, 2022
Product Code:
POS078490
Media Type:
Digital Seminar


Description

Keeping up with the latest research, ever-changing treatments and updates in psychopharmacology can be overwhelming. 
 
Decode the complexities of psychopharmacology with award-winning researcher, author and board-certified clinical psychiatric pharmacist, David Dadiomov, PharmD, BCPP.  
 
Designed for healthcare and mental health cliniciansincluding nurses, nurse practitioners, physician assistants, therapists, psychotherapists, psychologists and more – Dr. Dadiomov takes you beyond psychopharmacologic fundamentals in an easy and non-threatening way.  
 
You’ll get the knowledge you need to know to answer your patients' questions, manage complex side effects, understand medication reactions, and get specific strategies on…  
 
•    Warnings and contraindications for common medications to keep your patients safe 
•    How to give pregnant patients the highest level of care 
•    Disorder specific medication interventions to make treatment easier 
•    Treatment resistant psychiatric conditions, DSM-5-TR updates, and more 
 
Best of all, you’ll get access to case studies you can’t get anywhere else and a comprehensive reference guide so you can quickly apply your knowledge in any clinical or therapeutic setting. 
 
Whether you recommend or write prescriptions… you’ll get lasting treatment strategies you need to stay up to speed on a rapidly changing field to improve your treatment outcomes and protect your license!  

Credit

Program Information

Planning Committee Disclosure - No relevant relationships

All members of the PESI, Inc. planning committee have provided disclosures of financial relationships with ineligible organizations and any relevant non-financial relationships prior to planning content for this activity. None of the committee members had relevant financial relationships with ineligible companies or other potentially biasing relationships to disclose to learners.  For speaker disclosures, please see the faculty biography.



Canada Credit - *

NOTE: Tuition includes one free CE Certificate (participant will be able to print the certificate of completion after passing the online post-test (80% passing score) and completing the evaluation). Instructional methods will include PowerPoint, didactic lecture, and others.

Continuing Education Information:  Listed below are the continuing education credit(s) currently available for this non-interactive self-study package. Program content is reviewed periodically per accrediting board rules for currency and appropriateness for credit. Credit approvals are subject to change. Please note, your licensing board dictates whether self-study is an acceptable form of continuing education, as well as which credit types are acceptable for continuing education hours. Please refer to your licensing board's rules and regulations. If your profession is not listed, please contact your licensing board to determine your continuing education requirements and check for reciprocal approval. 
For other credit inquiries not specified below, please contact info@pesi.com or 800-844-8260 before purchase.

Materials that are included in this course may include interventions and modalities that are beyond the authorized practice of your profession.  As a licensed professional, you are responsible for reviewing the scope of practice, including activities that are defined in law as beyond the boundaries of practice in accordance with and in compliance with your profession's standards.  

For Planning Committee disclosures, please see the statement above.  For speaker disclosures, please see the faculty biography.

 


Canada Credit - ---

Earn up to 4.25 CE hours. Please see below, for more details, as credit amounts vary by jurisdiction and profession. 


Canada Credit - Canadian Counsellors and Psychotherapists

PESI, Inc. is approved by the Canadian Counselling and Psychotherapy Association to offer continuing education for counsellors and psychotherapists. PESI, Inc. maintains responsibility for the program. This self-study activity is approved for 4.0 credit hours.


Canada Credit - Social Workers - National ASWB ACE

PESI, Inc., #1062, is approved as an ACE provider to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Regulatory boards are the final authority on courses accepted for continuing education credit. ACE provider approval period: January 27, 2023 - January 27, 2026. Social workers completing this course receive 4.25 Clinical continuing education credits.

 

Course Level: Intermediate Format: Recorded asynchronous distance. Full attendance is required; no partial credits will be offered for partial attendance.

 

Canadian Social Workers: Canadian provinces may accept activities approved by the ASWB for ongoing professional development.


Canada Credit - Canadian Psychologists

PESI, Inc. is approved by the Canadian Psychological Association to offer continuing education for psychologists. PESI, Inc. maintains responsibility for the program. This program is approved for 4.0 self-study continuing education hours. Full credit statement at: www.pesi.com/cpa-statement


Canada Credit - Other Professions

This self-study activity qualifies for 4.25 continuing education clock hours as required by many national and local licensing boards and professional organizations. Save your activity advertisement and certificate of completion, and contact your own board or organization for specific requirements.


US National Boards - Nurses, Nurse Practitioners, and Clinical Nurse Specialists – ANCC

PESI, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. Nurses completing these self-study materials will earn 4.25 contact hours. Expires: 03/28/2026.



Handouts

Speaker

David Dadiomov, PharmD, BCPP's Profile

David Dadiomov, PharmD, BCPP Related seminars and products


David Dadiomov, PharmD, BCPP, is an assistant professor of clinical pharmacy in the Titus Family Department of Clinical Pharmacy at the USC Mann School of Pharmacy and Pharmaceutical Sciences.

He holds board certification in psychiatric pharmacy and serves as the director of the PGY2 Psychiatric Pharmacy Residency Program. He has led, co-led and conducted extensive research on opioid use disorders among vulnerable populations, prevalence and distribution of high-risk prescription opioid use, therapeutic drug monitoring, treatment-resistant psychiatric conditions and more. Dr. Dadiomov practices as a clinical pharmacy specialist in addiction and psychiatry at the Complex Care Clinic of the Los Angeles County Department of Health Services, one of the largest of its kind in the United States.

Dr. Dadiomov’s teaching approach is case focused, practical for any clinical setting, interactive and evidence supported. His expertise has been shared with experienced clinicians, graduate students and advanced level students. Dr. Dadiomov is the recipient of multiple awards for clinical excellence, teaching and clinical innovation and has presented, authored and co-authored multiple peer-reviewed journal articles, book chapters, and scientific presentations.

 

Speaker Disclosures:
Financial: Dr. David Dadiomov has employment relationships with the University of Southern California Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California Psychiatry and behavioral Sciences Medical Residency, and the Los Angeles County Department of Health Services. He previously received a speaking honorarium from Eli Lilly. Dr. Dadiomov receives grants from the 2024 SC CTSI Standard Pilot Grand Program, the USC Good Neighbors Grant Program, the Southern California Clinical and Translational Sciences Institute, and the Foundation for Opioid Response Efforts. He receives a speaking honorarium and recording royalties from Psychotherapy Networker and PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Dr. David Dadiomov is a member of the American Society of Addiction Medicine, the American Association of Psychiatric Pharmacists, the American College of Clinical Pharmacy, and the American Society of Health-System Pharmacists. He is a reviewer for several publications, for a complete list contact PESI.com.


Additional Info

Program Information

Access for Self-Study (Non-Interactive)

Access never expires for this product.

For a more detailed outline that includes times or durations of time, if needed, please contact cepesi@pesi.com


Questions?

Visit our FAQ page at https://www.pesicanada.com/faq or contact us at https://www.pesicanada.com/contact-us


Objectives

  1. Address misconceptions relating to psychopharmacology that can impact patient care
  2. Recognize evidence-based medication prescribing strategies to ensure optimal outcomes
  3. Ensure safety of prescribed medications through laboratory, patient assessment, and patient education
  4. Identify best counseling points for patient’s taking mental health medications
  5. Identify common concerns relating to medications for patients with mental health disorders
  6. Improve access to mental health care services 

Outline

Psychopharmacology for nursing professionals
  • Foundational concepts in psychopharmacology 
    • Drug targets
    • Neurotransmitters involved in treatment
  • Differential diagnosis in mental health conditions
    • Substance intoxication or withdrawal
    • Other mental health conditions
    • Other physical health conditions
    • How to screen and rule out other diagnoses
  • Practical Psychopharmacology for Depression Treatment
    • SSRIs
    • SNRIs
    • Atypical Antidepressants
    • New treatments
    • Adverse effects
      • Adverse effects that are applicable to the whole class
      • Specific adverse effect management
    • Efficacy of antidepressants and time course
  • Practical Psychopharmacology for Anxiety Treatment
    • SSRIs
    • SNRIs
    • Benzodiazepines
    • Buspirone
    • Hydroxyzine
  • Practical Psychopharmacology for Schizophrenia Treatment
    • Antipsychotics
      • 1st generation antipsychotics
      • 2nd generation antipsychotics
      • Clozapine
    • Therapeutic drug monitoring
    • Black box warnings
    • Long acting injectable antipsychotics
    • Management of acute agitation
  • Practical Psychopharmacology for Bipolar Disorder Treatment
    • Mood stabilizers
      • Lithium
      • Valproic acid
      • Lamotrigine
      • Carbamazepine
      • Second-generation antipsychotics
    • Therapeutic drug monitoring
    • Black box warnings

Pregnancy/lactation warnings

Target Audience

  • Addiction Counselors
  • Case Managers
  • Counselors
  • Marriage & Family Therapists
  • Nurses
  • Pharmacists
  • Psychologists
  • Social Workers
  • other Mental Health Professionals
  • other health care professionals
  • Physician Assistants
  • Nurse Practitioners

Reviews

Satisfaction Guarantee
Your satisfaction is our goal and our guarantee. Concerns should be addressed to info@pesicanada.com.

Please wait ...

Back to Top